Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
BMY 28142, a new broad-spectrum semisynthetic cephalosporin, was evaluated in vitro and in vivo in comparison with ceftazidime, cefotaxime, moxalactam, and cefoperazone. The activity of BMY 28142 compared favorably with the activities of the other compounds against both Pseudomonas aeruginosa and St...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1985
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176239/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3885849/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.2.207 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|